Syngene delivers comprehensive antibody generation and production services across polyclonal, hybridoma, and recombinant platforms. Whether for research, preclinical, or commercial programs, we help you design, produce, and scale with confidence.
From polyclonal to recombinant monoclonal antibodies, Syngene offers a full spectrum of solutions to match your research and development goals. Each approach is designed to deliver reliable quality, scalability, and scientific precision.
Our antibody production workflow is designed to give you clarity, flexibility, and confidence at every stage. From concept to scale-up, we apply scientific rigor and proven processes to deliver high-quality results.
At Syngene, antibody production is only the first step. Our comprehensive biologics ecosystem allows you to seamlessly advance your program from discovery through commercialization—reducing handoffs, saving time, and ensuring consistency.